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Abstract
Background: Japanese encephalitis (JE), a leading cause of viral encephalitis, is characterized by extensive
neuroinflammation following infection with neurotropic JE virus (JEV). Indoleamine 2,3-dioxygenase (IDO) has
been identified as an enzyme associated with immunoregulatory function. Although the regulatory role of
IDO in viral replication has been postulated, the in vivo role of IDO activity has not been fully addressed in
neurotropic virus-caused encephalitis.
Methods: Mice in which IDO activity was inhibited by genetic ablation or using a specific inhibitor were examined for
mortality and clinical signs after infection. Neuroinflammation was evaluated by central nervous system (CNS)
infiltration of leukocytes and cytokine expression. IDO expression, viral burden, JEV-specific T-cell, and type I/II interferon
(IFN-I/II) innate responses were also analyzed.
Results: Elevated expression of IDO activity in myeloid and neuron cells of the lymphoid and CNS tissues was closely
associated with clinical signs of JE. Furthermore, inhibition of IDO activity enhanced resistance to JE, reduced the viral
burden in lymphoid and CNS tissues, and resulted in early and increased CNS infiltration by Ly-6Chi monocytes, NK,
CD4+, and CD8+ T-cells. JE amelioration in IDO-ablated mice was also associated with enhanced NK and JEV-specific
T-cell responses. More interestingly, IDO ablation induced rapid enhancement of type I IFN (IFN-I) innate responses in
CD11c+ dendritic cells (DCs), including conventional and plasmacytoid DCs, following JEV infection. This enhanced
IFN-I innate response in IDO-ablated CD11c+ DCs was coupled with strong induction of PRRs (RIG-I, MDA5),
transcription factors (IRF7, STAT1), and antiviral ISG genes (Mx1, Mx2, ISG49, ISG54, ISG56). IDO ablation also enhanced
the IFN-I innate response in neuron cells, which may delay the spread of virus in the CNS. Finally, we identified that
IDO ablation in myeloid cells derived from hematopoietic stem cells (HSCs) dominantly contributed to JE amelioration
and that HSC-derived leukocytes played a key role in the enhanced IFN-I innate responses in the IDO-ablated
environment.
Conclusions: Inhibition of IDO activity ameliorated JE via enhancement of antiviral IFN-I/II innate and adaptive T-cell
responses and increased CNS infiltration of peripheral leukocytes. Therefore, our data provide valuable insight into the
use of IDO inhibition by specific inhibitors as a promising tool for therapeutic and prophylactic strategies against viral
encephalitis caused by neurotropic viruses.
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Background
Japanese encephalitis (JE) is an acute zoonotic, mosquito-
borne disease caused by JE virus (JEV), a single-stranded,
positive-sense RNA (~11 kb, monopartite, linear) virus
belonging to the family Flaviviridae and the genus Flavivi-
rus [1]. Infection with neurotropic flaviviruses of the JE
serotype, which include JE, Murray Valley encephalitis, St.
Louis encephalitis, and West Nile virus (WNV), results in
debilitating neurological disorders in a significant propor-
tion of clinical cases [2, 3]. JE is a leading cause of viral
encephalitis manifested by extensive neuroinflammation
in the central nervous system (CNS) and disruption of the
blood-brain barrier (BBB). In humans, the clinical presen-
tation of JEV infection ranges from mild febrile illness to
severe meningoencephalitis [4]. Due to rapid changes in
climate and demography, vector-transmitted JE poses an
increasing threat to global health and welfare with nearly
70,000 cases reported annually [5–7]. The incubation
period of JE ranges from 5 to 15 days, and most JEV infec-
tions in endemic regions manifest as mild febrile, subclin-
ical disease which leads to protective adaptive immune
responses [4]. However, approximately 25–30 % of JE
cases, mostly in infants, are lethal and 50 % of cases result
in permanent neuropsychiatric sequelae [4]. Thus, JE is
considered more fatal than encephalitis caused by WNV
infection, which has a fatality rate of 3–5 % (1100 deaths/
29,000 symptomatic infections) [7, 8]. Currently, more
than 60 % of the world’s population inhabits JE endemic
areas, such as eastern and southern Asia, and the virus is
spreading to previously unaffected regions, including
Indonesia, Pakistan, and northern Australia [5, 6]. How-
ever, despite the importance of JE, little is known regard-
ing potential therapeutic strategies for regulating JE
progression.
Indoleamine 2,3-dioxygenase (IDO) has been identified
as an enzyme associated with powerful immunoregula-
tory function, likely derived from its enzymatic activity,
which leads to catabolism of the essential amino acid
L-tryptophan (L-TRP) [9–14]. Therefore, IDO-mediated
depletion of L-TRP and the resulting metabolites
(L-kynurenine, L-KYN) induces an immunosuppressive
environment through provoking tolerogenicity of antigen-
presenting cells (APCs), T-cell anergy, and immune cell
death [9, 10]. IDO can be induced in a variety of cell types,
including dendritic cells (DCs) [15], macrophages [16], and
epithelial cells [17]. These cell types play an important role
in controlling viral replication and facilitating antigen-
specific adaptive immune responses [9, 10]. In various
tissues, IDO activity has been induced by several cytokines
after viral infection, and its enzymatic activity can be
blocked using the pharmacological competitive inhibitor,
1-methyl-D,L-tryptophan (1-MT) [18]. Thus, inhibition
of IDO with the competitive inhibitor 1-MT may be
a promising strategy for enhancing immune responses
in various viral infection models, including human im-
munodeficiency virus (HIV) and influenza virus [19, 20].
Also, IDO ablation was shown to suppress viral replication
through the upregulation of type I interferon (IFN-I)
production in a retrovirus-infected murine model [21].
Although the regulatory role of IDO in viral replica-
tion has been reported in a few studies using an in
vivo viral infection model, the in vivo role of IDO
activity is not fully understood in viral encephalitis
caused by infection with neurotropic viruses such as
JEV and WNV.
The molecular pathogenesis of viral encephalitis, includ-
ing JE, remains unclear. However, JE is considered an
immunopathological disease because CNS invasion by JEV
drives the stimulation of microglia/glia and infiltrating
leukocytes, leading to indirect death of neuron cells via the
uncontrolled secretion of pro-inflammatory cytokines
(such as IL-6 and TNF-α) and soluble mediators [22, 23].
Furthermore, JEV infects and kills neuron cells directly in
the CNS. This complicated progression of JE after viral in-
fection in the host prompted us to explore the role of IDO
in JE progression. Here, we found that IDO expression in
myeloid cells and in neurons of the lymphoid and CNS
tissues was closely associated with clinical signs of JE.
Furthermore, the inhibition of IDO activity using genetic
ablation or 1-MT provided enhanced resistance to JE,
along with a reduced viral burden and the early and in-
creased CNS infiltration of myeloid and lymphoid leuko-
cytes. JE amelioration was also associated with enhanced
NK and antigen-specific T-cell responses. More interest-
ingly, the rapid enhancement of IFN-I innate immune re-
sponses in CD11c+ DCs (conventional and plasmacytoid
DCs) and neuron cells likely contributed to the protective
role of IDO ablation in JE. Therefore, our data suggest
that the inhibition of IDO with pharmacological inhibitors




All animal experiments described in the present study
were conducted at Chonbuk National University accord-
ing to the guidelines set by the Institutional Animal Care
and Use Committees (IACUC) of Chonbuk National
University and were pre-approved by the Ethical Commit-
tee for Animal Experiments of Chonbuk National Univer-
sity (permission code 2013-0028). The animal research
protocol used in this study followed the guidelines set up
by the nationally recognized Korea Association for
Laboratory Animal Sciences (KALAS). All experimental
protocols requiring biosafety were approved by Institu-
tional Biosafety Committees (IBC) of Chonbuk National
University.
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Animals, cells, and viruses
C57BL/6 (H-2b) mice (4–5 weeks old) were purchased
from Samtako (O-San, Korea). IDO (H-2b) knockout
(KO) mice were obtained from The Jackson Laboratory
(Bar Harbor, ME, USA). All mice were genotyped and
bred in the animal facilities of Chonbuk National Uni-
versity. JEV Beijing-1 strain was obtained from Green
Cross Research Institute (Suwon, Korea) and propa-
gated in the mosquito cell line, C6/36, using DMEM
supplemented with 2 % FBS, penicillin (100 U/ml), and
streptomycin (100 U/ml) [24]. The C6/36 cultures were
infected with JEV Beijing-1 at a multiplicity of infection
(MOI) of 0.1 and were incubated in a humidified CO2
incubator for 1 h at 28 °C. After absorption, the inocu-
lum was removed, and 7 ml of a maintenance medium
containing 2 % FBS was added. Approximately 6–7 days
post-infection (dpi), cultures of host cells showing an
80–90 % cytopathic effect were harvested. The virus
stocks were titrated using either a conventional plaque
assay or a focus-forming assay and were stored in ali-
quots at −80 °C until use.
Antibodies and reagents
The mAbs used for flow cytometric analyses and other ex-
periments were obtained from eBioscience (San Diego, CA,
USA) or R&D Systems (Minneapolis, MN, USA): fluores-
cein isothiocyanate (FITC)-conjugated anti-CD4 (RM4-5),
CD8 (53-6.7), Ly-6G (1A8), B220 (RA3-6B2); phycoerythrin
(PE)-conjugated anti-mouse-CD11b (M1/70), Foxp3 (FJK-
16s), CD154 (MR1); peridinin chlorophyll protein complex
(PerCP)-conjugated anti-Ly-6C (HK1.4); PE-cyanine dye
(Cy5.5)-conjugated anti-mouse IFN-γ (XMG1.2); PE-
cyanine dye (Cy7)-conjugated anti-mouse NK1.1 (PK136),
IL-5 (TRFK4); and allophycocyanin (APC)-conjugated anti-
mouse-CD3ε (145-2c11), CD25 (PC62.5), CD49b (DX5),
Ly-6G (Gr-1), TNF-α (MP6-XT22), IL-4 (BVD6-24G2), and
IL-17A (eBio17B7). The peptides of I-Ab-restricted epitopes
(JEV NS1132–145 [TFVVDGPETKECPD] and NS3563–574
[WCFDGPRTNAIL]) and H-2Db-restricted epitopes (JEV
NS4B215–223 [SAVWNSTTA]) were chemically synthesized
at Peptron Inc. (Daejeon, Korea). JEV-specific primers for
the detection of viral RNA (JEV10,564–10,583 forward, 5′-
CCC TCA GAA CCG TCT CGG AA-3′ and JEV10,862–
10,886 reverse, 5′-CTA TTC CCA GGT GTC AAT ATG
CTG T-3′) and primers specific for cytokines, IFN-I (IFN-
α/β), and RLRs, IRFs, ISGs (Table 1) were synthesized at
Bioneer Corp. (Daejeon, Korea) and used for PCR amplifi-
cation of target genes.
Quantitative real-time RT-PCR for viral burden and cytokine
expression
Viral burden and the expression of cytokines (IL-6,
TNF-α, and IFN-α/β), CC chemokines, and IDO in in-
flammatory and lymphoid tissues were determined by
conducting quantitative SYBR Green-based real-time
RT-PCR (real-time qRT-PCR). Mice were infected intra-
peritoneally (i.p.) with JEV (3.0 × 107 plaque-forming
unit (PFU)) and tissues, including brain, spinal cord, and
spleen, were harvested at 2 and 4 dpi following extensive
cardiac perfusion with Hank’s balanced salt solution
(HBSS). Total RNA was extracted from tissues using
easy-BLUE (iNtRON, Inc., Daejeon, Korea) and sub-
jected to real-time qRT-PCR using a CFX96 Real-Time
PCR Detection system (Bio-Rad Laboratories, Hercules,
CA, USA). Following reverse transcription of total RNA
with the High-Capacity cDNA Reverse Transcription
Kits (Applied Biosystems, Foster, CA, USA), the reaction
mixture contained 2 μl of template cDNA, 10 μl of 2×
SYBR Premix Ex Taq, and 200 nM primers, yielding a
final volume of 20 μl. The reactions were denatured at
95 °C for 30 s and then subjected to 45 cycles of 95 °C
for 5 s and 60 °C for 20 s. After the reaction cycle was
complete, the temperature was increased from 65 to
95 °C at a rate of 0.2 °C/15 s, and the fluorescence was
measured every 5 s to construct a melting curve. A
control sample that contained no template DNA was
run with each assay, and all determinations were per-
formed at least in duplicates to ensure reproducibility.
The authenticity of the amplified product was deter-
mined by melting curve analysis. All data were analyzed
using the Bio-Rad CFX Manager, version 2.1 analysis
software (Bio-Rad Laboratories). Viral burden was
expressed by the copy number of viral RNA per micro-
gram of total RNA, after calculating the absolute copy
number of viral RNA in comparison with the standard
cDNA template of viral RNA.
Determination of L-kynurenine levels in the sera and brain
The levels of L-kynurenine in the sera and brain ho-
mogenates following JEV infection were measured via
HPLC after deproteination using a C18 reverse phase
column [25]. The levels of L-kynurenine in the sera and
brain homogenates were expressed as micromolars and
picomoles per milligram tissue, respectively. Levels of
L-kynurenine were used for an in vivo index of IDO en-
zyme activity.
Analysis of leukocyte infiltration into the CNS
Mice infected with JEV were perfused with 30 ml of HBSS
at 3 or 5 dpi via cardiac puncture of the left ventricle.
Brains were then harvested and homogenized by gently
pressing them through a 100-mesh tissue sieve, after
which they were digested with 25 μg/ml collagenase type
IV (Worthington Biochem, Freehold, NJ, USA), 0.1 μg/ml
trypsin inhibitor Nα-p-tosyl-L-lysine chloromethyl ketone,
10 μg/ml DNase I (Amresco, Solon, OH, USA), and
10 mM HEPE in HBSS for 1 h at 37 °C, under shaking
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conditions. Cells were separated using an Optiprep density
gradient (18/10/5 %) with centrifugation at 800×g for
30 min (Axis-Shield, Oslo, Norway), after which cells were
collected from the 18 to the 10 % interface and washed
twice with PBS. Cells were counted and stained for
CD11b, Ly6G, Ly6C, CD3ε, CD4, CD8α, DX5, and NK1.1
with directly conjugated antibodies (eBioscience) for
30 min at 4 °C. Finally, the cells were fixed with 10 % for-
maldehyde. Data collection and analysis were performed
with a FACSCalibur flow cytometer (Becton Dickson
Medical Systems Sharon, MA, USA) and FlowJo (Tree
Star, San Carlos, CA, USA) software.
Table 1 Specific primers for cytokines, chemokines, type I IFNs, and ISGs used in real-time qRT-PCR
Gene name Primer sequence (5′-3′) Position cDNA GeneBank ID
IL-6 FP: TGG GAA ATC GTG GAA ATG AG
RP: CTC TGA AGG ACT CTG GCT TTG
209–228442–462 NM_031168
TNF-α FP: CGT CGT AGC AAA CCA CCA AG








CCL2 FP: AAA AAC CTG GAT CGG AAC CAA
RP: CGG GTC AAC TTC ACA TTC AAA G
347–367426–447 NM_011333
CCL3 FP: CCA AGT CTT CTC AGC GCC AT
RP: GAA TCT TCC GGC TGT AGG AGA AG
158–177206–228 NM_011337.2
CCL4 FP: TTC TGT GCT CCA GGG TTC TC
RP: GAG GAG GCC TCT CCT GAA GT
128–147388–407 NM_013652.2
CCL5 FP: CCC TCA CCA TCA TCC TCA CT
RP: CTT CTT CTC TGG GTT GGC AC
77–96275–294 NM_013653.3
IRF3 FP: GAT GGA GAG GTC CAC AAG GA
RP: GAG TGT AGC GTG GGG AGT GT
1170–11891259–1278 NM_016849
IRF5 FP: GGA AGA AAT GAA GCC AGC AG
RP: ACC CTG GGG TAA TTG GAC TC
1931–19502001–2020 NM_001252382.1
IRF7 FP: CCT CTT GCT TCA GGT TCT GC
RP: GCT GCA TAG GGT TCC TCG TA
980–9991080–1099 NM_016850.3
RIG-I FP: CCA CCT ACA TCC TCA GCT ACA TGA
RP: TGG GCC CTT GTT GTT CTT CT
194–217260–279 NM_172689
MDA5 FP: GGC ACC ATG GGA AGT GAT T
RP: ATT TGG TAA GGC CTG AGC TG
1178–11961247–1266 NM_027835
PKR FP: AAC TTC TTC ACA CGT GCT TC
RP: CAT TCA GCC AAG GTC TTC AG
1517–15361678–1697 NM_011163
STAT1 FP: AAG CGA ACT GGA TAC ATC A
RP: CCG GGA CAT CTC ATC AAA C
2093–21112194–2212 U06924.1
2′5′-Oas1 FP: CCA TCC TCA AGT GGA CAA GAA CTG
RP: TTG GGC TTT GGG CAC CTT C
1235–12581359–1377 AF466822.1
Oasl-1 FP: CCA GGA AGA AGC CAA GCA CCA TC
RP: AGG TTA CTG AGC CCA AGG TCC ATC
377–399449–472 NM_145209.3
Mx1 FP: CAG CAC CTG ATG GCC TAT CA
RP: ACG TCT GGA GCA TGA AGA ACT G
2276–22952363–2342 NM_010846.1
Mx2 FP: AGG CTC ACA ACC GCA TCT
RP: GCT CAG CAA ACA TTT TCA GG
1858–18751910–1929 NM_013606.1
ISG49 FP: GCC GTT ACA GGG AAA TAC TGG
RP: CCT CAA CAT CGG GGC TCT
919–9391126–1143 NM_010501.2
ISG54 FP: GGG AAA GCA GAG GAA ATC AA
RP: TGA AAG TTG CCA TAC AGA AG
1918–19372005–2024 NM_008332.3
ISG56 FP: CAG AAG CAC ACA TTG AAG AA
RP: TGT AAG TAG CCA GAG GAA GG
774–793911–930 NM_008331.3
β-actin FP: TGG AAT CCC TGT GGG ACC ATG AAA C
RP: TAA AAC GCA GCT CAG TAA CAG TCC G
885–9091209–1233 NM_007393.3
IL interleukin, TNF-α tumor necrosis factor-α, IFN interferon, FP forward primer, RP reverse primer
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Analysis and activation of NK cells
The activity of NK cells was assessed by their capacity to
produce IFN-γ and granzyme B (GrB) following brief
stimulation with PMA and ionomycin (Sigma-Aldrich, St.
Louis, MO, USA). Splenocytes were prepared from BL/6
and IDO KO mice 2 dpi and stimulated with PMA (50 ng/
ml) and ionomycin (750 ng/ml) for 1 and 2 h, respectively,
in the presence of monensin (2 μM) to induce the accu-
mulation of IFN-γ and GrB. After stimulation, cells were
surface-stained with FITC anti-mouse-CD3ε, PE-Cy7 anti-
mouse NK1.1, biotin-conjugated anti-mouse pan-NK cells
(CD49b) [DX5] antibodies, and streptavidin-APC for
30 min at 4 °C. Cells were then washed twice with FACS
buffer containing monensin. After fixation, the cells were
permeabilized with 1× permeabilization buffer (eBioscience)
and stained intracellularly with PE anti-mouse IFN-γ
(XMF1.2) and GrB antibodies in permeabilization buffer
for 30 min at 4 °C. Finally, the cells were washed twice
with PBS, and analysis was performed with a FACSCalibur
flow cytometer (Becton Dickson Medical Systems) and
FlowJo software (ver. 7.6.5; Tree Star).
JEV-specific CD4+ and CD8+ T-cell responses
JEV-specific CD4+ and CD8+ T-cell responses were deter-
mined by intracellular CD154 [26, 27], IFN-γ, and TNF-α
staining in response to stimulation with JEV epitope
peptides. Surviving mice infected with 3.0 × 107 PFU JEV
were sacrificed at 7 dpi, and splenocytes were prepared.
The erythrocytes were depleted by treating single-cell sus-
pensions with ammonium chloride-containing Tris buffer
(NH4Cl-Tris) for 5 min at 37 °C. The splenocytes were
cultured in 96-well culture plates (5 × 105 cells/well) in the
presence of synthetic peptide epitopes (NS1132–145, NS3563–
574, and NS4B215–225) for 12 and 6 h, in order to observe
CD4+ and CD8+ T-cell responses, respectively. Monensin
at a concentration of 2 μM was added to antigen-
stimulated cells 6 h before harvest. Cells were washed twice
with PBS and surface-stained with FITC-anti-CD4 or CD8
antibodies for 30 min at 4 °C, and then washed twice with
PBS containing monensin. After fixation, the cells were
washed twice with permeabilization buffer (eBioscience)
and stained with PE Cy5.5-anti-IFN-γ or APC-anti-TNF-α
in permeabilization buffer for 30 min at room temperature.
Intracellular CD154 was detected by the addition of CD154
mAb to culture media during peptide stimulation. Finally,
the cells were washed twice with PBS and fixed using
fixation buffer. Sample analysis was performed with a
FACSCalibur flow cytometer (Becton Dickson Medical Sys-
tems) and FlowJo (Tree Star) software.
Intracellular staining for analysis of CD4+ Th1, Th17, and
Treg cells
To monitor CD4+ Th subsets, mice were infected i.p. with
3.0 × 107 PFU of JEV, sacrificed at 5 dpi, and splenocytes
were prepared. Splenocytes were then cultured in 96-well
culture plates (106 cells/well) with PMA/Ionomycin (Th1
and Th17) in the presence of monensin (2 μM) for 5 h at
37 °C. The stimulated cells were washed twice with PBS
and surface stained with FITC-anti-CD4 for 30 min at 4 °
C and then washed twice with PBS containing monensin.
After fixation, the cells were washed twice with
permeabilization buffer (eBioscience) and stained with
PerCP-anti-IFN-γ and APC-anti-IL-17α in permeabilization
buffer for 30 min at room temperature. Finally, the cells
were washed twice with PBS and fixed using fixation buffer.
To monitor Treg cells, splenocytes were stained by surface
staining for FITC-anti-CD4 markers for 30 min on ice and
then fixed with fixation/permeabilization concentrate buffer
(eBioscience) for 6 h at 4 °C. After fixation, the cells were
washed twice with permeabilization buffer (eBioscience)
and stained with PE-anti-Foxp3 in permeabilization buffer
for 30 min at room temperature. The sample analysis was
performed using a FACSCalibur flow cytometer.
Primary cell culture and infection
Myeloid-derived DCs and macrophages
Bone marrow-derived conventional DCs (BMDCs), plasma-
cytoid DCs (pDCs), and macrophages (BMDMs) were pre-
pared from BM cells from BL/6 and IDO KO mice, as
described earlier with some modifications [24]. Briefly, for
BMDCs and pDCs, BM cells (3 × 105 cells/ml) from femurs
and tibiae were cultured in RPMI 1640 supplemented with
GM-CSF (2 ng/ml) plus IL-4 (10 ng/ml) and Flt3-L (10 ng/
ml), respectively. On day 3, another 6 ml of fresh complete
medium containing GM-CSF plus IL-4 and Flt3-L was
added, and half of the medium was changed on day 6. On
day 8, non-adherent and loosely adherent DCs were har-
vested by vigorous pipetting. Cells were then characterized
by flow cytometric analysis, which revealed that the culture
generally consisted of >85 % CD11c+ cells (25 % CD11c
+CD11b+ and 65 % CD11c+CD8α+), and >90 % CD11c
+PDCA-1+B220+. BMDMs were prepared by culturing
bone marrow cells in DMEM supplemented with 30 %
L929 cell-conditioned medium (LCCM) as a source of
macrophage colony-stimulating factor (M-CSF). On day 3,
another 6 ml of fresh complete medium containing 30 %
LCCM was added, and half of the medium was changed on
day 6. The cultured cells were harvested following an 8-day
incubation and were analyzed by flow cytometry. The pre-
pared BMDMs were composed of >85 % F4/80+ cells that
consisted of 99.2 % F4/80+CD11b+ and ~1 % F4/80+CD11c+
cells. Prepared BMDCs, pDCs, and BMDMs were infected
with JEV at MOIs of 0.1, 1.0, and 10 for analysis of viral
replication and 10 MOI for evaluating cytokine expression.
Primary microglia
Primary microglia cells were recovered from the brains of
fetal BL/6 and IDO KO mice (1–3 days old), as described
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previously [28]. Primary microglia cells recovered from the
brains via trypsin + EDTA digestion were initially seeded on
poly-D-lysine/laminin-coated plates in DMEM containing
10 % FBS and mechanically isolated from glia cells by a
brief duration of shaking (100 rpm, 1 h). Primary microglia
cells were infected with JEV at MOIs of 1.0 and 10 for ana-
lysis of viral replication and 10 MOI for the evaluation of
cytokine, IFN-I, RLR, and ISG gene expression.
Primary cortical neurons
Primary cortical neurons were prepared from 15-day-old
embryos, as described previously [24]. Cortical neurons
were seeded in 12-well poly-D-lysine/laminin-coated plates
in DMEM containing 5 % FBS and 5 % horse serum for
24 h, and then cultured for 4 days with Neurobasal medium
containing B27 supplement and L-glutamine (Invitrogen,
Carlsbad, CA, USA). Primary cortical neurons were in-
fected with JEV at MOIs of 0.001 and 0.01 for analysis of
viral replication and 0.1 MOI for the evaluation of cytokine
expression.
Generation of BM chimeric mice and determination of
serum IFN-β
BL/6 mice (5 weeks old) and IDO KO mice were irradiated
with one dose of 900 rads. Within 12 h, recipient mice were
reconstituted with 107 donor BM cells derived from BL/6
and IDO KO mice. The recipient mice were given sulfa-
methoxazole and trimethoprim in their drinking water for
10 days after irradiation. Mice were infected with JEV 4–
6 weeks after irradiation. A commercial ELISA kit (PBL
Biomedical Laboratories, Piscataway, NJ, USA) was used to
measure levels of secreted IFN-β protein in sera according
to the manufacturer’s protocol.
Statistical analysis
All data were expressed as the average ± standard deviation,
and statistically significant differences between groups were
analyzed by unpaired two-tailed Student’s t tests for ex vivo
experiments and immune cell analyses or ANOVA and
post hoc test for multiple comparisons of the mean. The
statistical significance of viral burden was evaluated using
the Mann-Whitney test or unpaired two-tailed Student’s t
test. Kaplan-Meier survival curves were analyzed with the
log-rank test. A p value of ≤0.05 was considered significant.
All data were analyzed using Prism software (GraphPad
Prism4, San Diego, CA, USA).
Results
IDO expression correlates with clinical signs of JE
To determine whether IDO expression changes during
JE progression, several tissues obtained from JEV-
infected BL/6 mice were used to evaluate IDO mRNA
expression at the early stage of infection (from 0 to 3
dpi) prior to the presentation of neurological disorders.
As shown in Fig. 1a, JEV infection induced no apparent
changes in the expression of IDO in the examined tis-
sues, including lymphoid (spleen, mesenteric LN, bone
marrow), extraneural (liver), and CNS tissues (brain,
spinal cord) prior to the onset of neurological disorders.
In general, infected mice showed clinical signs starting
with generalized piloerection, paresis, and rigidity,
which then progressed to severe neurological signs,
such as postural imbalance, ataxia, and generalized
tonic-clonic seizure, by 4 to 5 dpi. Thus, we were inter-
ested in testing whether IDO expression varies between
mice showing clinical signs, such as paralysis, and mice
displaying no clinical signs. To this end, mice were di-
vided into two populations showing either paralysis or
no paralysis 5 dpi, the point at which approximately
30–40 % of infected mice showed neurological disor-
ders, and the expression of IDO mRNA was evaluated
in several tissues. Interestingly, enhanced induction of
IDO expression was observed only in lymphoid tissues
(spleen and bone marrow) and the CNS (brain and
spinal cord) of mice showing paralysis compared to
mice showing no paralysis (Fig. 1b). However, other
extraneural tissues, including mesenteric LN and liver,
showed no apparent increases in expression of IDO in
paralyzed mice. IDO expression at the protein level was
also confirmed by Western blotting using total lysates
derived from several tissues. In agreement with the
enhanced induction of IDO mRNA expression in para-
lyzed mice, mice showing paralysis displayed an appar-
ent increase in the expression of IDO protein in
lymphoid tissues (spleen, bone marrow) and neural tis-
sues (brain and spinal cord) (Fig. 1c). DCs and macro-
phages in peripheral tissues are the primary target cells
of JEV, and neuron cells support JEV replication after
the virus gains access into the CNS. Also, microglia,
tissue-resident macrophages in the CNS are believed to
regulate neuroinflammation caused by various insults.
Therefore, we evaluated IDO expression in primary
myeloid-derived DCs, pDCs, macrophages, microglia,
and primary cortical neuron cells after JEV infection.
Conventional DCs (BMDCs), pDCs, macrophages
(BMDMs), microglia, and neuron cells displayed differ-
ent dynamic patterns of IDO expression, depending on
the time after JEV infection (Fig. 1d). pDCs showed the
most rapid expression of IDO, with levels peaking at
24 h pi, whereas BMDCs displayed a delayed expression
pattern with the levels peaking at 48 h pi. IDO was also
expressed in macrophages with gradual and moderate
increases in levels up to 72 h pi, and microglia showed
basal levels of IDO expression up to 24 h pi and in-
creased levels thereafter. Neuron cells showed a gradual
increase in IDO expression with approximately fivefold
higher levels at 72 h pi compared to levels in the mock-
infected group. This result indicates that the primary
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target cells in the periphery and CNS tissues can ac-
tively express IDO with different intrinsic patterns in
response to JEV infection. Collectively, these results
indicate that IDO expression in myeloid cells and
neurons of the lymphoid and CNS tissues is closely
associated with the clinical signs of JE. Notably, IDO
expression in the neural tissues (brain and spinal cord)
was likely to be coupled with neurological disorders
such as paralysis.
Blockage of IDO provides enhanced resistance to JE
Because IDO expression in lymphoid and neural tissues
was closely associated with JE progression, we were inter-
ested in investigating the role of IDO during JE progression.
BL/6 mice infected with JEV showed gradually elevated
release of the tryptophan catabolite L-kynurenine by cells
expressing functional IDO enzyme activity in the sera and
brain homogenates relative to basal levels in IDO KO mice
(Fig. 2a), which suggests that IDO expression increases
during JE progression. Also, we examined and compared
the susceptibility of IDO-deficient (KO) mice to JE caused
by neurotropic JEV infection with that of wild-type BL/6
mice (Fig. 2b). The ablation of IDO resulted in a markedly
increased survival rate of 55 % in IDO KO mice vs. 18 % in
BL/6 mice after JEV infection (3.0 × 107 PFU) (left curve in
Fig. 2b), thereby signifying significantly enhanced resistance
to JE. Likewise, IDO KO mice showed delayed signs of
neurological disorder starting 5–6 dpi compared to BL/6
mice, which displayed signs of neurological disorder sooner
and in a higher proportion of animals (middle graph in
Fig. 2b), and IDO ablation resulted in less change in body
weight (right graph in Fig. 2b). These results indicate that
Fig. 1 IDO expression is correlated with clinical signs of JE. a IDO expression at the early stage of JE. IDO expression was determined by real-time qRT-PCR
using total RNA extracted from several tissues, including the spleen (Spl), mesenteric LN (MLN), bone marrow (BM), brain (Br), spinal cord (SC), and liver (Liv),
1, 2, and 3 days following JEV infection. b Comparison of IDO expression between aparalytic and paralytic hosts. IDO expression was determined by
real-time qRT-PCR using total RNA extracted from several tissues in mice showing a neurological disorder such as paralysis (paralytic) and mice showing no
paralytic symptoms (aparalytic) 5 dpi. c Detection of IDO protein during JE progression. IDO protein levels in several tissues of JEV-infected mice were
evaluated by Western blot using a monoclonal antibody specific for IDO. Differences in IDO protein levels between aparalytic and paralytic hosts were
evaluated after mice were divided into groups showing either aparalytic (AP) or paralytic symptoms (P) 5 dpi. d IDO expression in primary myeloid cells,
microglia, and cortical neurons after JEV infection. Bone marrow-derived DCs (BMDCs), plasmacytoid DCs (pDCs), macrophages (BMDMs), microglia, and
primary cortical neurons were infected with JEV (10 MOI for BMDCs, pDCs, BMDMs, and microglia; 0.01 MOI for neurons) and IDO expression was
determined by real-time qRT-PCR at the indicated time points. The levels of IDO expression were expressed as fold relative to mock-infected cells (0 h).
*p< 0.05; **p< 0.01; ***p< 0.001 compared to levels in the indicated groups
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Fig. 2 (See legend on next page.)
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IDO ablation ameliorates JE progression. Furthermore, we
tested the effect of the IDO-specific inhibitor 1-methyl-[D]-
tryptophan (1-MT) on JE progression. As suggested by our
other results, oral treatment with 1-MT resulted in reduced
mortality, delayed neurological disorder, and less change in
body weight compared to untreated BL/6 mice (Fig. 2c).
Therefore, this result strengthens our finding that IDO
ablation provides enhanced resistance to JE. To better
understand JE progression in IDO-ablated mice, we exam-
ined viral burden in peripheral lymphoid and CNS tissues
after JEV infection. IDO KO mice were observed to contain
less amount of virus, with around a tenfold decrease in the
spleen and brain compared to levels in BL/6 mice (Fig. 2d).
Ultimately, these results suggest that IDO ablation amelio-
rates JE progression by regulating the viral burden in per-
ipheral lymphoid and CNS tissues.
Blockage of IDO results in early and increased CNS
infiltration by myeloid and lymphoid leukocytes
CNS infiltration by CD11b+Ly-6Chi monocytes is a hall-
mark of CNS inflammation caused by neurotropic viral
infection [29]. These cells migrate into the infected brain,
where they differentiate into DC, macrophage, and
microglia populations [30–33]. Although the potential con-
tribution of CD11b+Ly-6Chi monocytes to neuroinflamma-
tion remains controversial, CNS infiltration by CD11b+Ly-
6Chi monocytes is believed to support their protective role
during lethal neuroinflammation [34–37]. Therefore, in
order to better understand the amelioration of JE in IDO
KO mice, we examined CNS infiltration by leukocytes, in-
cluding CD11b+Ly-6Chi monocytes, during JE progression.
Wild-type BL/6 and IDO KO mice contained comparable
levels of CD11b+Ly-6Chi monocytes and CD11b+Ly-6Ghi
granulocytes in the brain before JEV infection. However,
the frequency of CD11b+Ly-6Chi monocytes gradually
increased in the CNS of IDO KO mice during JE progres-
sion (Fig. 3a). Also, CNS infiltration by CD11b+Ly-6Ghi
granulocytes was transiently increased in IDO KO mice 3
dpi, after which the Ly-6Ghi granulocyte frequency was
comparable in both BL/6 and IDO KO mice 5 dpi. Simi-
larly, the accumulated total number of CNS-infiltrated Ly-
6Chi monocytes and Ly-6Ghi granulocytes was increased in
IDO KO mice, compared to those of BL/6 mice (Fig. 3b).
Furthermore, because CD4+ Th1, CD8+, and NK cells may
play beneficial roles in controlling JE progression [38–41],
we examined CNS infiltration of NK, CD4+, and CD8+ T-
cells. As with CNS infiltration by Ly-6Chi monocytes, CNS
infiltration by NK, CD4+, and CD8+ T-cells was observed
to gradually increase in IDO KO mice compared to levels
observed in BL/6 mice (Fig. 3c, d). Notably, CD8+ T-cells
showed marked infiltration with threefold increased levels
in the CNS of IDO KO mice. With respect to CNS inflam-
mation, the expression of cytokines and chemokines within
the CNS may be required to fully explain encephalitis, be-
cause encephalitis caused by neurotropic viruses is indir-
ectly derived from CNS degeneration caused by robust
immunological responses, such as the uncontrolled
secretion of cytokines, including TNF-α, and the re-
sultant activation of microglia and astrocytes [22, 23].
Therefore, we examined the expression of TNF-α and
CC chemokines in the CNS. Our results revealed that
the expression of CC chemokines was comparable in
both BL/6 and IDO KO mice, except that the expres-
sion levels of TNF-α and CCL2 were modestly de-
creased in IDO KO mice (Fig. 3e). This result implies
that CC chemokine expression may not play a role in
increased CNS infiltration by Ly-6Chi monocytes, NK,
CD4+, and CD8+ T-cells. Collectively, these results
suggest that IDO ablation allows for early and in-
creased CNS infiltration by myeloid and lymphoid
leukocytes, which may mediate the early control of
viral replication in the CNS.
IDO ablation enhances the activation of NK cells during JE
Antiviral innate NK cell activation is believed to play
an important role in regulating JE progression
through the control and clearance of JEV in extra-
neural and neural tissues [38]. Therefore, in order to
characterize the immunological parameters associated
with control of JEV replication in IDO KO mice, we
examined and compared NK cell responses in both
BL/6 and IDO KO mice. Because JEV was adminis-
tered intraperitoneally, analysis of the spleen provides
insight into how IDO modulates the innate immune
and inflammatory responses during the early phase
of infection. Analysis of splenic NK cells revealed
that BL/6 mice exhibited a reduction in CD3−NK1.1
+DX5+ NK cells following JEV infection (Fig. 4a), as
(See figure on previous page.)
Fig. 2 Blockage of IDO enhances resistance to JE and reduces viral burden. a Levels of L-kynurenine in the sera and brain of BL/6 and IDO KO mice.
Following JEV infection, levels of L-kynurenine in the sera and brain homogenates were estimated by HPLC at different time points. b Susceptibility of IDO-
ablated mice to JE. BL/6 and IDO KO mice (4 to 5 weeks old, n= 25–30) were inoculated i.p. with JEV (3.0 × 107 PFU) and examined over 15 days for their
survival. c Enhanced resistance to JE by IDO inhibition. BL/6 mice were infected i.p. with JEV and administered an IDO inhibitor (1-MT, 1 and 2 mg per
mouse) every day. Left graph, curve showing survival rates; middle graph, proportion of mice showing neurological disorders during JE progression every
6 h from 4 to 11 dpi; right graph, changes in body weight. Changes in body weight were expressed as the mean percentage ± SD of body weight relative
to the time of challenge. d Viral burden in lymphoid and inflammatory tissues during JE. Viral burden in the spleen and brain of infected mice was assessed
by real-time qRT-PCR at the indicated time points post-infection. The viral RNA load was expressed as viral RNA copy number per microgram of total RNA
(n= 5–7). *p< 0.05; **p< 0.01; ***p< 0.001 compared with levels in the indicated groups or in BL/6 control mice
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if wild-type mice previously showed decreased num-
ber of NK cells [24]. However, IDO KO mice showed
less of a reduction in the number of CD3−NK1.1
+DX5+ NK cells. Consequently, an increase in the
total number of splenic NK cells was detected in
IDO KO mice compared to BL/6 mice. Moreover,
when the activation of NK cells was evaluated by the
production of IFN-γ and granzyme B from NK cells,
the frequency and the total number of CD3−NK1.1
+DX5+ NK cells producing IFN-γ and granyzme B
were apparently increased in IDO KO mice (Fig. 4b,
c). Therefore, this result indicates that increased acti-
vation of NK cells plays a role in the early control of
JEV replication, thereby resulting in the amelioration
of JE progression.
Enhancement of JEV-specific CD4+ and CD8+ T-cell responses
by IDO ablation
In addition to NK cells, adaptive immune responses specific
for JEV antigen are required for the regulation of JE
progression through peripheral control of JEV replication
[38–41]. Furthermore, IDO may in some cases affect
antigen-specific antibody responses [42, 43], which contrib-
ute to the control of JEV dissemination and replication in
the brain. Our data revealed that IDO ablation induced no
significant changes in serum IgM and IgG specific for JEV
antigen (Fig. 5a). Because IDO is known to suppress T-cell-
mediated adaptive immune responses in a range of clinic-
ally relevant syndromes, including autoimmune, allergic,
and infectious diseases [9, 10], we also evaluated CD4+ and
CD8+ T-cell responses specific for JEV antigen in surviving
BL/6 and IDO-ablated mice 7 dpi. IDO ablation resulted in
moderately increased JEV-specific CD4+ T-cell responses
when CD4+ T-cell responses were evaluated by intracellular
CD154, IFN-γ, and TNF-α staining in response to stimula-
tion with two epitope-peptides (NS1132–145 and NS3563–574)
derived from JEV (Fig. 5b). Consistent with this finding, the
total number of CD4+ T-cells producing IFN-γ or TNF-α
in response to JEV epitope stimulation was higher in IDO-
ablated mice (Fig. 5c). Furthermore, somewhat interestingly,
IDO-ablated mice displayed markedly increased CD8+ T-
cell responses with three- to fivefold higher levels, com-
pared to BL/6 mice (Fig. 5d), and consistently contained a
higher total number of JEV-specific CD8+ T-cells producing
Fig. 3 IDO ablation results in early and increased CNS infiltration by myeloid and lymphoid leukocytes. a, b The frequency and number of Ly-6Chi
monocytes and Ly-6Ghi granulocytes in the CNS. The frequency (a) and total number (b) of Ly-6Chi monocytes and Ly-6Ghi granulocytes in the
CNS were determined by flow cytometric analyses 3 and 5 dpi using vigorous heart perfusion. Values presented in the representative dot plots
denote the average percentage of the indicated population after gating on CD11b+ cells (n = 4–5). c, d Accumulated number of NK cells, CD4+,
and CD8+ T-cells in the CNS. Total accumulated number of NK cells (CD3−NK1.1+DX5+), CD4+ (CD3+CD4+), and CD8+ (CD3+CD8+) T-cells in the
CNS were enumerated by flow cytometric analysis 3 and 5 dpi. e The expression of TNF-α and CC chemokines in the CNS. The expression levels
of TNF-α and CC chemokines were determined by real-time qRT-PCR using total RNA extracted from brain tissue 2 dpi. Data show the average ±
SD of the indicated cell populations derived from at least five mice per group. *p < 0.05; **p < 0.01; ***p < 0.001 compared with levels in the
indicated groups
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IFN-γ or TNF-α in response to a JEV CD8+ T-cell epitope
(NS4B215–223) (Fig. 5e). These results indicate that the
increased CD4+ and CD8+ T-cell responses generated in
IDO-ablated mice could contribute to the control of JE pro-
gression during the late stage of infection.
IDO ablation induces a skewed IFN-γ+CD4+ Th1 response
during JE
CD4+CD25+Foxp3+ Treg cells may contribute to control-
ling lethal neuroinflammation caused by neurotropic
viruses [44]. In contrast, IL-17+CD4+ Th17 cells play a
critical role in autoimmune and virus-caused immuno-
pathologic diseases by facilitating pathologic consequences
through neutrophil recruitment [45, 46]. The generation
of CD4+CD25+Foxp3+ Tregs is reciprocally linked with
IL-17+CD4+ Th17 and IFN-γ+CD4+ Th1 cells [47, 48]. Be-
cause IDO may regulate the equilibrium of CD4+Foxp3+
Tregs and IL-17+CD4+ Th17 cells in inflammatory
diseases [49, 50], we examined the generation of each
CD4+ Th subset, including CD4+Foxp3+ Tregs, IL-17
+CD4+ Th17, and IFN-γ+CD4+ Th1 cells, early during JE
progression. Our results revealed that IDO-ablated mice
showed no significant alterations in the frequency or num-
ber of CD4+CD25+Foxp3+ Tregs, compared to wild-type
BL/6 mice (Fig. 6a, b). In contrast, IFN-γ+CD4+ Th1 cells
were detected at higher levels in IDO-ablated mice, and
the frequency and number of IL-17+CD4+ Th17 cells were
not changed by IDO ablation (Fig. 6c, d). Therefore, this
result suggests that the increase in IFN-γ+CD4+ Th1 cells
in IDO-ablated mice contributes in part to the control of
JE progression during the early stage of infection.
IDO ablation enhances innate IFN-I responses of CD11c+
DCs following JEV infection
Myeloid cells, including DCs and macrophages, are the
primary target cells of JEV infection in the peripheral
tissues and function to regulate the spread of virus to
distant tissues such as the CNS [23]. Furthermore, mye-
loid cells can produce IFN-I via PRR recognition upon
JEV infection, which plays a crucial role in controlling
viral replication [51, 52]. Additionally, IDO ablation
appears to regulate viral replication via IFN-I production
[21]. Because viral loads at the periphery in IDO-ablated
mice were lower than in wild-type BL/6 mice, we evalu-
ated the contribution of DC subsets (conventional and
plasmacytoid) and macrophages to the IFN-I innate
immune responses caused by JEV infection in the IDO-
ablated environment. In order to assess the role of IDO
Fig. 4 Enhancement of NK cell activation by IDO ablation. a NK cell frequency and number. The frequency and absolute number of CD3−NK1.1
+DX5+ NK cells in the spleen were determined by flow cytometric analysis 2 dpi. Values in representative dot plots on the left denote the
average percentage of splenic NK cells derived from at least four mice per group, after gating on CD3− cells; the bar graph on the right denotes
the average ± SD of splenic NK cell numbers derived from at least four mice per group. b, c Activation of NK cells. The activation of CD3−NK1.1+DX5+
NK cells was evaluated by intracellular IFN-γ and granzyme B (GrB) staining upon stimulation with PMA plus ionomycin. Values in the representative
dot plots on the left denote the average percentage of IFN-γ- or GrB-producing NK cells derived from at least four mice per group; the bar graphs on
the right show the average number ± SD of NK cells producing IFN-γ or GrB in the spleens of at least four mice per group. **p < 0.01; ***p < 0.001
compared with levels in the indicated groups
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Fig. 5 (See legend on next page.)
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in inducing the IFN-I innate response of JEV-infected
DC subsets and macrophages, BMDCs, pDCs, and mac-
rophages (BMDMs) prepared from IDO-ablated mice
were infected with JEV and used to evaluate viral replica-
tion and the induction of IFN-I and pro-inflammatory cy-
tokines. Interestingly, IDO-ablated BMDCs and pDCs, but
not BMDMs, showed significantly lower JEV replication
(Fig. 7a–c). Notably, BMDCs derived from IDO-ablated
mice exhibited impaired JEV replication throughout the
examination period compared to replication in cells from
wild-type BL/6 mice. Furthermore, the inhibition of JEV
replication in BMDCs and pDCs derived from IDO-
ablated mice was closely associated with enhanced expres-
sion of IFN-I (IFN-α/β) following JEV infection (Fig. 7d).
IDO-ablated BMDCs and pDCs, but not BMDMs, showed
rapid induction of IFN-α/β in response to JEV infection
compared to levels measured in cells from wild-type BL/6
mice. However, it was curious that pDCs showed less
apparent regulation of viral replication than BMDCs,
despite pDCs inducing stronger IFN-I innate responses.
Presumably, this discrepancy is related to cell-intrinsic
properties or other mechanisms involved in regulating
viral replication. In addition, rapid and increased induc-
tion of IL-6 and TNF-α mRNAs was observed upon JEV
infection in IDO-ablated BMDCs (Fig. 7e). Collectively,
these results imply that rapid and increased IFN-I innate
responses in CD11c+ DC subsets (conventional DCs and
pDCs) may contribute to the early control of viral replica-
tion in the absence of IDO. To further characterize IFN-I
innate responses in JEV-infected DC subsets derived from
IDO-ablated mice, we also measured the induction levels
of ISG genes. We specifically focused on pattern recogni-
tion receptors ( PRRs; RIG-I [DDX1], MDA5 [IFITH1],
PKR), transcription factors (STAT1, IRF3, IRF7), IFN-
induced antivirus-related genes (Oas1, Oasl-1, Mx1,
Mx2), and several ISG genes (ISG49 [IFIT3], ISG54
[IFIT2], ISG56 [IFIT1]). Our results revealed that BMDCs
and pDCs derived from IDO-ablated mice showed rapid
and enhanced expression of the STAT1, Oas1, Mx1, Mx2,
and ISG genes with slightly different patterns at 24 h pi,
whereas BMDMs derived from IDO-ablated mice showed
either no alteration or a slight decrease in the expression
of PRRs, IFR3 and IRF7, and ISG genes (Fig. 8). Also, it
was interesting that BMDCs and pDCs derived from IDO-
ablated mice displayed early enhanced induction of PRRs
(RIG-I and MDA5) and their transcription factor (IRF7) at
24 h pi. This indicates that rapid and increased expression
of ISG genes in JEV-infected BMDCs and pDCs follows
the inhibition of JEV replication via enhanced expression
of IFN-α/β. Collectively, IDO ablation appears to provide
rapid and increased responses of IFN-I innate immunity in
myeloid-derived DCs and pDCs upon JEV infection,
thereby contributing to the amelioration of JE through
early control of viral replication.
Viral replication and innate immune responses of IDO-
ablated microglia in response to JEV infection
Microglia cells are CNS-resident macrophages that
play an important role in regulating the neuroinflam-
mation caused by sterile and non-sterile insults [53].
Bystander damage caused by pro-inflammatory media-
tors released from microglia likely contributes to the
exacerbation of JE progression. Furthermore, because
IDO-ablated microglia are considered to show stron-
ger inflammatory responses after the virus gains ac-
cess to the CNS, we examined the innate immune
responses of primary microglia cells derived from the
brain of fetal BL/6 and IDO KO mice in response to
JEV infection. Our results revealed that primary
microglia recovered from the brain of IDO-ablated
mice showed similar innate immune responses to JEV
infection as shown in macrophages derived from BM
cells of IDO KO mice. IDO-ablated microglia were
observed to allow JEV replication with moderately but
not significantly lower levels compared to those of
BL/6 mice (Fig. 9a). Consistent with this, IDO-ablated
microglia displayed no apparent enhancement of IFN-
I innate responses when the expression of IFN-α/β
and ISG genes (ISG49, ISG54, ISG56) was examined
(Fig. 9b, c). Also, no significant differences in the ex-
pression of RLRs and transcription factors IRF3 and
IRF7 were observed between microglia derived from
IDO KO and BL/6 mice (Fig. 9d, e), and both IDO-
ablated and wild-type microglia showed comparable
expression of pro-inflammatory cytokines TNF-α and
IL-6 in response to JEV infection (Fig. 9f ). Therefore,
these results indicate that microglia could not provide
dominant contribution to the regulation of JEV
(See figure on previous page.)
Fig. 5 IDO ablation enhances CD4+ and CD8+ T-cell responses specific for JEV antigen. a JEV E-specific IgM and IgG response. Sera were collected
from surviving mice 7 dpi and used in ELISA to detect IgM and IgG levels specific for the JEV E protein. The data show the average ± SD of the JEV
E-specific IgM and IgG levels derived from surviving mice (n= 6–8). b, c CD4+ T-cell response specific for JEV antigen. The splenocytes prepared from
surviving mice (n= 4–5) were stimulated with the JEV epitope peptides of CD4+ T-cells (NS1132–145 and NS3563–574) for 12 h. The frequency (b) and absolute
number (c) of CD4+ T-cells specific for the JEV epitope peptides were determined by intracellular CD154, IFN-γ, or TNF-α staining, combined with surface
CD4 staining. d, e CD8+ T-cell response specific for JEV antigen. The frequency (d) and absolute number (e) of CD8+ T-cells specific for the JEV epitope
peptide (NS4B215–223) were determined by intracellular IFN-γ or TNF-α staining after an 8-h stimulation with peptide. Values in the representative dot
plots denote the average percentage of the indicated cell population, and the bar charts show the average ± SD of the values derived from at least
four mice per group. *p < 0.05; **p < 0.01; ***p < 0.001 compared with levels in the indicated groups
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dissemination and JE progression in the CNS under
an IDO-ablated environment.
Induction of IFN-I and ISG in primary cortical neurons
derived from IDO KO mice after JEV infection
Neurons are the main target cell of JEV replication within
the CNS, and their death is a key factor in the pathogen-
esis and neurological sequelae of JEV [23]. Furthermore,
neuron cells have also been shown to produce antiviral
IFN-I in response to viral infection and are consequently
involved in controlling viral replication in the CNS [54, 55].
Therefore, we examined viral replication and IFN-I innate
immune responses in primary cortical neuron cells gener-
ated from wild-type BL/6 and IDO-ablated mice after JEV
infection. Consistent with the results obtained from
BMDCs and pDCs, primary cortical neurons derived from
IDO-ablated mice showed transiently reduced JEV replica-
tion (Fig. 10a). This transient reduction of JEV replication
in IDO-ablated neurons was associated with significantly
increased induction of IFN-I (IFN-α/β), relative to the levels
measured in cells from wild-type BL/6 mice (Fig. 10b).
Also, it seemed that the expression of antiviral ISG genes
(ISG49, ISG54, ISG59) in IDO-ablated neurons followed
IFN-I innate responses and the transient reduction in viral
replication (Fig. 10c), whereas the expression levels of tran-
scription factors (IRF3, IRF7), but not PRRs (RIG-I,
MDA5), were decreased by JEV infection (Fig. 10d, e).
Therefore, these results suggest that the ablation of IDO
could provide enhanced IFN-I innate immune responses in
neuron cells to regulate the spread of JEV in the CNS.
Fig. 6 IDO induces a skewed IFN-γ+CD4+ T-cell response during JE. a, b The frequency and number of CD4+Foxp3+ Tregs in the spleen of IDO-ablated
mice. The frequency (a) and absolute number (b) of CD4+Foxp3+ Treg cells in the spleen of wild-type and IDO KO mice were determined by flow
cytometric analysis 5 dpi. The values in the representative dot plots show the average percentage of CD25+Foxp3+ cells in CD4+ T-cells; the bar charts
denote the average number ± SD of CD4+Foxp3+ Tregs in the spleen derived from at least four mice per group. c, d The frequency and number of IFN-
γ+CD4+ Th1 and IL-17+CD4+ Th17 cells in the spleen of IDO-ablated mice. The frequency and number of IFN-γ+CD4+ Th1 and IL-17+CD4+ Th17 cells were
determined by intracellular cytokine staining of the splenocytes prepared from wild-type and IDO KO mice 5 dpi in response to PMA + ionomycin
stimulation. The values in the representative dot plots show the average percentage of the indicated cell populations after gating on CD4+ T-cells; the
bar charts denote the average number ± SD of IFN-γ+CD4+ Th1 and IL-17+CD4+ Th17 cells in the spleen derived from at least four mice per group.
**p < 0.01 compared with levels in the indicated groups
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Fig. 7 (See legend on next page.)
Kim et al. Journal of Neuroinflammation  (2016) 13:79 Page 15 of 23
IDO ablation in HSC-derived leukocytes alleviates JE via
enhancement of the IFN-I innate response
Our results support the idea that IDO ablation amelio-
rates JE progression by provoking potent antiviral IFN-I
innate responses in myeloid-derived DCs and pDCs at
the periphery. Therefore, we were interested in confirm-
ing whether myeloid cells derived from hematopoietic
stem cells (HSCs) play a dominant role in regulating JE
progression in IDO-ablated mice via the induction of
enhanced IFN-I innate responses. To this end, we used a
BM chimeric model of wild-type BL/6 and IDO-ablated
mice. In support of our hypothesis, our results revealed
that myeloid cells derived from HSCs played a dominant
role in conferring amelioration of JE in the IDO-ablated
environment. Specifically, wild-type BL/6 recipients of
IDO KO BM donor cells (KO-WT) showed enhanced
resistance to JE, compared to the IDO KO recipients of
wild-type BL/6 BM donor cells (WT-KO) and wild-type
BL/6 recipients of wild-type BL/6 BM donor cells (WT-
WT) (Fig. 11a). Furthermore, KO-WT and KO-KO BM
chimeric models showed less change in body weight
after JEV infection compared to the other BM chimeric
models (Fig. 11b). Also, potent and rapid IFN-I innate
immune responses were observed in KO-WT and
KO-KO BM chimeric models compared to those ob-
served in the WT-WT BM chimeric model, as evalu-
ated by the determination of serum IFN-β (Fig. 11c).
This result indicates that myeloid cells derived from
HSCs of IDO-ablated mice play a dominant role in
the IFN-I innate response in IDO KO hosts. Collect-
ively, it appears that the ablation of IDO in myeloid
cells derived from HSCs has an important role in
ameliorating JE by inducing a potent and rapid IFN-I
innate immune response.
Discussion
In this study, IDO expression from myeloid and neuron
cells located in extraneural and neural tissues during JE
progression appears to be closely associated with clinical
signs such as neurological disorders. Furthermore, we dem-
onstrated that inhibition of IDO activity through genetic
ablation or use of an IDO inhibitor (1-MT) enhanced the
resistance to JE progression induced by JEV infection. In
our mechanistic studies on the role of IDO in regulating JE
Fig. 8 The expression of RLR, IRF, and ISG genes in BMDCs, BMDMs, and pDCs following JEV infection. BMDCs, BMDMs, and pDCs recovered
from WT and IDO KO mice were infected with JEV at a MOI of 10 and used to analyze the induction of IRF, ISG, and RLR genes at 24 and 48 h pi. The
expression of each IRF, ISG, and RLR gene was normalized to that of β-actin after determining the mRNA levels by real-time qRT-PCR and displayed as the
average of at least four independent samples, according to the indicated color on a log2 scale
(See figure on previous page.)
Fig. 7 IFN-I innate immune responses of IDO-ablated myeloid-derived cells after JEV infection. Primary bone marrow-derived conventional DCs
(BMDCs), plasmacytoid DCs (pDCs), and macrophages (BMDMs) recovered from BL/6 and IDO KO mice were infected with JEV at MOIs of 0.1, 1.0, and 10
for viral replication and 10 for cytokine expression. JEV replication and the expression of cytokines and IFN-α/β were evaluated by real-time qRT-PCR using
extracted total RNA. a–c JEV replication in BMDCs, BMDMs, and pDCs. d, e IFN-α/β, IL-6, and TNF-α expression in BMDCs, pDCs, and BMDMs. The bar charts
show the average ± SD of the values derived from BMDCs, BMDMs, and pDCs assayed in quadruplicates. *p< 0.05; **p< 0.01; p< 0.001 compared with
levels in the indicated groups
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progression, IDO-ablated mice showed early and increased
CNS infiltration by myeloid cells (Ly-6Chi monocytes and
Ly-6Ghi granulocytes) and lymphoid cells (CD3−NK1.1
+DX5+ NK, CD4+, and CD8+ T-cells), which were associ-
ated with a reduced viral burden in the CNS. IDO ablation
increased the activity of cytolytic effector cells following
JEV infection, due to the enhancement of IFN-γ or gran-
zyme B-producing NK cells and JEV-specific CD8+ T-cell
responses in IDO-ablated mice. In addition, the enhanced
production of IFN-γ from CD4+ Th1 cells in response to
JEV antigen might contribute to early viral clearance from
extraneural and neural tissues of IDO-ablated mice. Also,
somewhat intriguingly, our data revealed that potent and
rapid IFN-I innate immune responses in CD11c+ DCs and
neuron cells following JEV infection could effectively regu-
late the spread of JEV in IDO-ablated mice. This finding
was supported by the results that IDO ablation in myeloid
cells derived from HSCs played a dominant role in amelior-
ating JE and that IDO-ablated HSC-derived leukocytes were
major contributors to IFN-I innate responses in the host.
Collectively, our data suggest that the ablation of IDO
activity with specific inhibitors, such as 1-MT, could be a
valuable therapeutic tool for the treatment of JE.
IDO is considered a negative regulator of the immune
system because IDO activity in APCs, including DCs and
macrophages, is a potent mechanism for inducing im-
munosuppression and tolerance. Therefore, it is probable
that the attenuation of immunosuppressive IDO activity
leads to enhanced innate and adaptive immune responses
for viral clearance. Indeed, the inhibition of IDO activity
with a specific inhibitor resulted in enhanced CD4+ Th1-
type and CD8+ T-cell responses specific to the influenza
virus [20]. Furthermore, the inhibition of IDO activity
reportedly modifies the immunodominance hierarchy by
increasing the number of CD8+ T-cells specific to a sub-
dominant epitope derived from the influenza virus. The
ablation of IDO also suppresses viral replication in
retrovirus-infected mice through IFN-I production [21].
These findings strongly support our data that IDO abla-
tion ameliorates JE progression through enhanced type I/
II IFN innate and adaptive immune responses. Although
the in vivo role of IDO after viral infection has been inves-
tigated in a few studies using murine infection models, the
regulatory role of IDO in neuroinflammation caused by
neurotropic viruses, such as JEV, has not been addressed
to date. To the best of our knowledge, our findings pro-
vide the first evidence that IDO inhibition could regulate
the in vivo progression of viral encephalitis caused by
neurotropic viruses such as JEV and WNV.
The molecular pathogenesis of JE remains unclear, but
JE is considered an immunopathological disease since un-
controlled over-activation of microglia/glia and infiltrated
leukocytes after CNS invasion of JEV drives neurological
disorders [22, 23]. Although CNS infiltration by peripheral
innate and adaptive immune cells appears to play a critical
role in host defense against infections with neurotropic vi-
ruses such as JEV, control of CNS infiltration is also re-
quired because excessive or inappropriate CNS infiltration
can cause profound damage. Therefore, the outcome of JE
pathogenesis appears to depend on the complicated inter-
play between virus-induced tissue damage and host im-
mune response against JEV antigens. CNS infiltration by
CD11b+Ly-6Chi monocytes is a hallmark of neuroinflam-
mation caused by neurotropic viruses. These CD11b+Ly-
Fig. 9 Viral replication and innate immune responses of IDO-ablated microglia in response to JEV infection. Primary microglia recovered from BL/
6 and IDO KO mice were infected with JEV at MOIs of 1.0 and 10 for viral replication and 10 for cytokine expression. JEV replication and
the expression of cytokines, IFN-α/β, RLRs, ISGs, and IRF transcription factors were evaluated by real-time qRT-PCR using extracted total
RNA at the indicated time point or 24 h pi. a JEV replication. b, c The expression of IFN-α/β and the ISG gene. d, e RLR and IRF expression. f TNF-α and
IL-6 expression. The bar charts show the average ± SD of values derived from primary microglia assayed in quadruplicates
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6Chi monocytes migrate into the inflamed CNS, where
they differentiate into DCs, macrophages, and microglia
to regulate neuroinflammation [30–37]. Although con-
flicting roles have been postulated for Ly-6Chi monocytes
in CNS inflammation, CNS infiltration by CD11b+Ly-6Chi
monocytes is essential in the control of neuroinflamma-
tion caused by neurotropic viruses, which supports their
protective role during CNS inflammation [34–37]. Not-
ably, the differentiation state of Ly-6Chi monocytes that
infiltrate into the CNS appears to affect the progression of
neuroinflammation caused by various insults [56–58].
Supportively, IDO ablation was observed to lead to en-
hanced CNS infiltration of CD11b+Ly-6Chi monocytes,
which may contribute to a beneficial outcome in JE. Fur-
thermore, early and increased infiltration of NK, CD4+,
and CD8+ T-cells in the CNS of IDO-ablated mice appears
to play a role in reducing the viral burden, because infil-
tration of NK, CD4+ Th1, and CD8+ T-cells producing
Fig. 10 Induction of IFN-I and ISGs in primary cortical neurons derived from IDO KO mice after JEV infection. Primary cortical neurons generated
from BL/6 and IDO KO mice were infected at MOIs of 0.001 and 0.01, and viral replication and IFN-I responses 24, 48, and 72 h pi were analyzed
by real-time qRT-PCR. a JEV replication. b IFN-I (IFN-α/β) expression. c–e Induction of ISGs, RLRs, and IRFs in infected primary cortical neuron. The
expression of IFN-I (b), ISGs (c), RLRs (d), and IRFs (e) was determined using primary cortical neuron infected with JEV (0.1 MOI) 24 h pi. The bar
charts show the average ± SD of values derived from primary cortical neurons in quadruplicate. *p < 0.05; **p < 0.01; ***p < 0.001 compared with
levels in the indicated groups
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IFN-γ is required for early clearance of the virus from the
CNS [38–41]. After peripheral introduction of JEV via
mosquito bites, JEV initially replicates in its primary target
cells, including DCs and macrophages, at the periphery
and subsequently gains entry into the CNS through the
BBB. Presumably, JEV-specific CD4+ Th1 and CD8+ T-cell
responses generated in the peripheral lymphoid tissues of
IDO-ablated mice would likely provide more effective
control of viral replication, thereby reducing the amount
of virus supplied from the periphery. In support of this
notion, our data revealed that the viral burden in the
extraneural and neural tissues of IDO-ablated mice were
lower than those in wild-type BL/6 mice. The depletion or
adoptive transfer of specific cell populations of NK and
CD8+ T-cells was previously reported to provide no signifi-
cant contribution to host survival and viral clearance [38].
Furthermore, co-transfer of immune CD4+ and CD8+ T-
cells, but not individual transfer of either T-cell subpopula-
tion, significantly contributed to a favorable JE outcome
and promoted host survival [40]. These facts suggest the
possibility that enhancement of broad immunity, including
NK, CD4+ Th1, and cytotoxic CD8+ T-cells, in IDO-
ablated mice accounts for the effective regulation of early
viral clearance in extraneural and neural tissues, thereby
providing protection against JE progression without tissue
injury. However, IDO ablation did not result in any signifi-
cant change in the humoral immune responses specific for
JEV antigen. The effects of IDO on the humoral immune
response appear to be variable, depending on the experi-
mental model used [42, 43]. Because B-cell-deficient (μMT)
mice uniformly succumbed to viral encephalitis caused by
flaviviruses in a previous study, one obvious conclusion is
that an early and sustained humoral immune response is
absolutely essential to surviving infection with JEV and
other related flaviviruses [59]. This notion suggests a limita-
tion that IDO inhibition may not provide the perfect pro-
tection against JE progression due to the lack of substantial
enhancement in the humoral response against JEV antigen.
Thus, further studies on how to enhance the humoral
immune response are needed in the context of IDO
inhibition.
The requirement of IFN-γ in the recovery from infections
with flaviviruses has been shown to be variable. IFN-γ
provides an early protective immune response against a
virulent North American isolate of WNV [60] and mouse-
adapted strains of dengue virus [61, 62], whereas IFN-γ is
dispensable in the control of infection with less virulent
strains of WNV [63] or of yellow fever virus [64, 65]. Add-
itionally, IFN-γ shows only a modest protective role against
Murray Valley encephalitis [66]. Similarly, in the JE model,
Fig. 11 IDO ablation in HSC-derived leukocytes alleviates JE via enhancement of the IFN-I innate response. BM cells from WT or IDO KO mice
were grafted to lethally irradiated WT or IDO KO recipient mice, which were then infected with JEV (3.0 × 107 PFU). a Susceptibility of IDO KO BM
chimeric models to JE. Infected recipient mice (n = 12) were examined over 18 days to determine the survival rate. b Changes in body weight.
Data are expressed as the average percentage of body weight relative to the time of challenge. c Systemic IFN-β levels in an IDO KO BM chimera.
The amount of serum IFN-β was determined by ELISA at the indicated time points. *p < 0.05; **p < 0.01 compared with levels in WT-WT BM
chimera 48 h pi. #p < 0.05; ##p < 0.01 compared with levels in WT-WT BM chimera 72 h pi
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IL-12-mediated induction of IFN-γ has been reported to
result in suppressed protective immunity [67], whereas
IFN-γ was associated with a beneficial effect on the out-
come of JE [38]. Our data favor the latter result, showing a
beneficial role of IFN-γ in JE progression, because IDO
ablation markedly increased IFN-γ-producing NK, CD4+
Th1, and CD8+ T-cells. IFN-γ is believed to play diverse
roles in infectious diseases, including the activation and
polarization of CD4+ Th cells, upregulation of Fas in in-
fected target cells, upregulation of MHC I and II-restricted
Ag-presentation pathways, macrophage activation, and dir-
ect antiviral activity that overlaps with activities triggered
by IFN-I [68]. Also, IFN-γ produced from CD4+ Th1 and
CD8+ T-cells in IDO-ablated mice is believed to induce the
maturation of Ly-6Chi monocytes, which may contribute to
better JE outcomes [69, 70]. However, IFN-γ-producing NK
cells do not appear to significantly contribute to host sur-
vival, because NK-cell-depleted mice showed no change in
viral burden or survival [38]. Furthermore, flaviviruses in-
cluding WNV exhibit immune escape from NK cell attack
via the upregulation of MHC-I in infected cells [71]. In con-
trast, antigen-specific CD8+ T-cell cytolytic activity on in-
fected target cells is thought to play a crucial role in disease
recovery, given that depletion of CD8+ T-cells resulted in
an increased viral burden in the CNS [40]. Supportively,
our data revealed that IDO ablation provided marked
enhancement of CD8+ T-cells producing IFN-γ and TNF-α
upon JEV Ag stimulation. In addition, IDO ablation in-
duced an increase in CD4+ Th1 cells producing IFN-γ at
the early stage, but IL-17+CD4+ Th17 and CD4+Foxp3+
Tregs were not altered by the ablation of IDO. Collectively,
these findings suggest that IFN-γ produced from CD4+
Th1 and CD8+ T-cells play an important role in regulating
JE progression in IDO-ablated mice.
The role of IDO in antiviral activity has been postulated
in different in vitro experiments. For example, IDO activity
in astrocytes is induced by the TLR3 ligand polyinosinic-
polycytidylic acid, which is involved in antiviral function via
the exhaustion of the essential amino acid L-TRP in the
environment [72]. This finding is inconsistent with our
data, but it is notable that this finding was derived from an
in vitro model. The intriguing result in the present study
was that IDO-ablated CD11c+ DCs, including conventional
and plasmacytoid DCs, showed potent and rapid IFN-I
innate immune responses to JEV infection. Also, KO-KO
and KO-WT BM chimeric models showed systemic IFN-β
production at levels higher than in WT-WT and WT-KO
BM chimeric models. This supports the notion that mye-
loid cells derived from HSCs, including CD11c+ DCs, may
dominantly contribute to the rapid IFN-I innate immune
response. This result is strengthened by the finding that
IDO KO and 1-MT-treated mice showed induction of a
markedly increased IFN-I innate response in the spleen
following retrovirus infection [21]. Conventional and
plasmacytoid DCs exhibited potent and rapid IFN-I innate
responses with different dynamic patterns in the expression
of PRRs, transcription factors, and ISG genes following JEV
infection. These different IFN-I innate responses in both
types of CD11c+ DCs are thought to be derived from the
intrinsic properties of the specific cell type. Although we
did not investigate the detailed mechanism by which IDO-
ablated CD11c+ DCs displayed a potent IFN-I response to
JEV infection, our data suggest the involvement of PRRs
(RIG-I, MDA5) and transcription factor IRF7 because the
expression levels of RIG-I, MDA5, and IRF-7 were rapidly
enhanced in IDO-ablated CD11c+ DCs. Also, considering
that only a small fraction (10–20 %) of myeloid-derived
cells are infected by JEV [73], uninfected myeloid-derived
cells are thought to contribute substantially to the induc-
tion of antiviral ISGs through early stimulation of the
STAT1 transcription factor which induces ISG49, ISG54,
and ISG56 [24]. Also, it is worth noting that primary cor-
tical neuron cells derived from IDO-ablated mice showed
potent IFN-I innate responses resulting in delayed replica-
tion of JEV. Although the induction patterns of PRRs and
their transcription factors in neuron cells differed from
those of CD11c+ DCs following JEV infection, the induction
of ISGs in IDO-ablated neurons definitely followed potent
IFN-I innate immune responses, such as IFN-αβ produc-
tion. However, because cortical neurons are relatively
insensitive to the antiviral effects of IFN-I [74], the regula-
tion of viral replication in primary cortical neurons by IFN-I
innate responses may ultimately show some limitations.
Indeed, our data indicating that primary cortical neuron
cells derived from IDO KO mice showed transient inhib-
ition of viral replication support this speculation. Therefore,
further studies are needed to define the mechanistic and
functional intermediates that link IDO to the regulation of
IFN-I innate immune responses in different cell types.
JE pathogenesis in the murine model may be affected by
the route of administration, dosage, and strain of the virus,
and the virus propagation conditions used [23]. IDO was
expressed with different dynamic patterns in conventional
and plasmacytoid DCs, macrophages, and neuron cells
upon JEV infection. Thus, it is thought that JE pathogen-
esis may also be affected by how the innate responses of
specific cell types are exhibited after JEV infection. Rapid
IFN-I/II innate immune responses are considered more
crucial in the control of JE progression than adaptive T-
cell responses, which take time to develop. Considering
that IDO ablation provided early and enhanced IFN-I/II
innate responses and subsequent adaptive T-cell response
in the host, the inhibition of IDO may be a valuable tool
for regulating JE progression.
Conclusions
The inhibition of IDO ameliorates JE progression via rapid
enhancements in IFN-I/II innate immune responses and
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CNS infiltration by Ly-6Chi monocytes. Also, IDO ablation
may accelerate viral clearance from the host at a later stage
via the enhancement of JEV-specific IFN-γ-producing T-
cell responses. Therefore, these results suggest that inhi-
bition of IDO activity by specific inhibitors [75, 76] may be
a promising tool for therapeutic and prophylactic strategies
against JE.
Abbreviations
BBB: blood-brain barrier; BM: bone marrow; BMDC: bone marrow-derived dendritic
cell; BMDM: bone marrow-derived macrophage; dpi: days post-infection;
HSC: hematopoietic stem cell; IDO: indoleamine 2,3-dioxygenase; IFN-I/II: type I/II
interferon; JE: Japanese encephalitis; KO: knockout; pDC: plasmacytoid dendritic
cell; PRRs: Pattern recognition receptors; WNV: West Nile virus.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SBK and JYC conceived the study and discussed the data with SKE. EU, AMP,
and FMAH conceived the study and contributed to the experimental design.
JH, SYP, JHL, and KK contributed to the reagent/materials/analysis and tools and
provided critical conceptual guidance. SBK and SKE wrote the paper with
contributions from all authors. All of the authors reviewed and approved the
final version of the manuscript.
Acknowledgements
This study was supported by a National Research Foundation of Korea (NRF)
grant funded by the Korean Government (MISP) (2013R1A4A1069486). The
funder had no role in study design, data collection and analysis, the decision
to publish, or preparation of the manuscript.
Author details
1College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk
National University, Iksan 54596, Republic of Korea. 2Department of Bioactive
Material Sciences, Graduate School, Chonbuk National University, Jeonju
54896, Republic of Korea. 3Department of Pharmacology, School of Medicine,
Pusan National University, Yangsan 50612, Republic of Korea.
Received: 22 December 2015 Accepted: 12 April 2016
References
1. Weaver SC, Powers AM, Brault AC, Barrett AD. Molecular epidemiological
studies of veterinary arboviral encephalitides. Vet J. 1999;157:123–38. doi:10.
1053/tvjl.1998.0289.
2. King NJ, Getts DR, Getts MT, Rana S, Shrestha B, Kesson AM.
Immunopathology of flavivirus infections. Immunol Cell Biol. 2007;85:33–42.
doi:10.1038/sj.icb.7100012.
3. Go YY, Balasuriya UB, Lee CK. Zoonotic encephalitides caused by
arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.
Clin Exp Vaccine Res. 2014;3:58–77. doi:10.7774/cevr.2014.3.1.58.
4. Misra UK, Kalita J. Overview: Japanese encephalitis. Prog Neurobiol. 2010;91:
108–20. doi:10.1016/j.pneurobio.2010.01.008.
5. Le Flohic G, Porphyre V, Barbazan P, Gonzalez JP. Review of climate,
landscape, and viral genetics as drivers of the Japanese encephalitis virus
ecology. PLoS Negl Trop Dis. 2013;7, e2208. doi:10.1371/journal.pntd.
0002208.
6. Daep CA, Munoz-Jordan JL, Eugenin EA. Flaviviruses, an expanding threat in
public health: focus on dengue, West Nile, and Japanese encephalitis virus.
J Neurovirol. 2014;20:539–60. doi:10.1007/s13365-014-0285-z.
7. Center for Disease. Japanese encephalitis: status of surveillance and
immunization in Asia and the Western Pacific, 2012. MMWR Morb Mortal
Wkly Rep. 2013;62:658–62.
8. Center for Disease. West Nile Virus activity—human disease cases reported.
2005–2009. 2009. Http://www.cdc.gov/ncidod/dvbid/westnile/ sur&control.
htm. Accessed 4 Sept 2014
9. Mbongue JC, Nicholas DA, Torrez TW, Kim NS, Firek AF, Langridge WH. The
role of indoleamine 2, 3-dioxygenase in immune suppression and
autoimmunity. Vaccines(Basel). 2015;3:703–29. doi:10.3390/vaccines3030703.
10. Ball HJ, Jusof FF, Bakmiwewa SM, Hunt NH, Yuasa HJ. Tryptophan-
catabolizing enzymes—party of three. Front Immunol. 2014;5:485. doi:10.
3389/fimmu.2014.00485.
11. Coutinho LG, Christen S, Bellac CL, Fontes FL, Souza FR, Grandgirard D, et al.
The kynurenine pathway is involved in bacterial meningitis. J
Neuroinflammation. 2014;11:169. doi:10.1186/s12974-014-0169-4.
12. Yan EB, Frugier T, Lim CK, Heng B, Sundaram G, Tan M, et al. Activation of
the kynurenine pathway and increased production of the excitotoxin
quinolinic acid following traumatic brain injury in humans. J
Neuroinflammation. 2015;12:110. doi:10.1186/s12974-015-0328-2.
13. Liu R, Li X, Zhang Z, Zhou M, Sun Y, Feng X, et al. Allogeneic mesenchymal
stem cells inhibited T follicular helper cell generation in rheumatoid arthritis.
Sci Rep. 2015;5:12777. doi:10.1038/srep12777.
14. Ankrum JA, Dastidar RG, Ong JF, Levy O, Karp JM. Performance-enhanced
mesenchymal stem cells via intracellular delivery of steroids. Sci Rep. 2014;4:
4645. doi:10.1038/srep04645.
15. Fallarino F, Vacca C, Orabona C, Belladonna ML, Bianchi R, Marshall B, et al.
Functional expression of indoleamine 2,3-dioxygenase by murine CD8
alpha(+) dendritic cells. Int Immunol. 2002;14:65–8.
16. Yeung AW, Wu W, Freewan M, Stocker R, King NJ, Thomas SR. Flavivirus
infection induces indoleamine 2,3-dioxygenase in human monocyte-derived
macrophages via tumor necrosis factor and NF-kappaB. J Leukoc Biol. 2012;
91:657–66. doi:10.1189/jlb.1011532.
17. van Wissen M, Snoek M, Smids B, Jansen HM, Lutter R. IFN-gamma amplifies
IL-6 and IL-8 responses by airway epithelial-like cells via indoleamine 2,3-
dioxygenase. J Immunol. 2002;169:7039–44.
18. Jia L, Schweikart K, Tomaszewski J, Page JG, Noker PE, Buhrow SA, et al.
Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of
toxicity due to saturating absorption. Food Chem Toxicol. 2008;46:203–11.
doi:10.1016/j.fct.2007.07.017.
19. Potula R, Poluektova L, Knipe B, Chrastil J, Heilman D, Dou H, et al.
Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of
virus-infected macrophages in an animal model of HIV-1 encephalitis. Blood.
2005;106:2382–90. doi:10.1182/blood-2005-04-1403.
20. Sage LK, Fox JM, Mellor AL, Tompkins SM, Tripp RA. Indoleamine 2,3-
dioxygenase (IDO) activity during the primary immune response to
influenza infection modifies the memory T cell response to influenza
challenge. Viral Immunol. 2014;27:112–23. doi:10.1089/vim.2013.0105.
21. Hoshi M, Saito K, Hara A, Taguchi A, Ohtaki H, Tanaka R, et al. The absence
of IDO upregulates type I IFN production, resulting in suppression of viral
replication in the retrovirus-infected mouse. J Immunol. 2010;185:3305–12.
doi:10.4049/jimmunol.0901150.
22. Saxena V, Mathur A, Krishnani N, Dhole TN. An insufficient anti-inflammatory
cytokine response in mouse brain is associated with increased tissue
pathology and viral load during Japanese encephalitis virus infection. Arch
Virol. 2008;153:283–92. doi:10.1007/s00705-007-1098-7.
23. Kimura T, Sasaki M, Okumura M, Kim E, Sawa H. Flavivirus encephalitis:
pathological aspects of mouse and other animal models. Vet Pathol. 2010;
47:806–18. doi:10.1177/0300985810372507.
24. Han YW, Choi JY, Uyangaa E, Kim SB, Kim JH, Kim BS, et al. Distinct dictation
of Japanese encephalitis virus-induced neuroinflammation and lethality via
triggering TLR3 and TLR4 signal pathways. PLoS Pathog. 2014;10, e1004319.
doi:10.1371/journal.ppat.1004319.
25. Laich A, Neurauter G, Widner B, Fuchs D. More rapid method for
simultaneous measurement of tryptophan and kynurenine by HPLC. Clin
Chem. 2002;48:579–81.
26. Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M, et al.
Direct access to CD4+ T cells specific for defined antigens according to
CD154 expression. Nat Med. 2005;11:1118–24. doi:10.1038/nm1292.
27. Chattopadhyay PK, Yu J, Roederer M. Live-cell assay to detect antigen-
specific CD4+ T-cell responses by CD154 expression. Nat Protoc. 2006;1:1–6.
doi:10.1038/nprot.2006.1.
28. Chen X, Zhang Y, Sadadcharam G, Cui W, Wang JH. Isolation, purification,
and culture of primary murine microglia cells. Bio-protocol. 2013;3:e314.
http://www.bio-protocol.org/e314. Assessed 14 Mar 2016.
29. Terry RL, Getts DR, Deffrasnes C, van Vreden C, Campbell IL, King NJ.
Inflammatory monocytes and the pathogenesis of viral encephalitis. J
Neuroinflammation. 2012;9:270. doi:10.1186/1742-2094-9-270.
Kim et al. Journal of Neuroinflammation  (2016) 13:79 Page 21 of 23
30. Ashhurst TM, van Vreden C, Niewold P, King NJ. The plasticity of
inflammatory monocyte responses to the inflamed central nervous system.
Cell Immunol. 2014;291:49–57. doi:10.1016/j.cellimm.2014.07.002.
31. Ohgidani M, Kato TA, Setoyama D, Sagata N, Hashimoto R, Shigenobu K,
et al. Direct induction of ramified microglia-like cells from human
monocytes: dynamic microglial dysfunction in Nasu-Hakola disease.
Sci Rep. 2014;4:4957. doi:10.1038/srep04957.
32. Cazareth J, Guyon A, Heurteaux C, Chabry J, Petit-Paitel A. Molecular and
cellular neuroinflammatory status of mouse brain after systemic
lipopolysaccharide challenge: importance of CCR2/CCL2 signaling. J
Neuroinflammation. 2014;11:132. doi:10.1186/1742-2094-11-132.
33. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Shrestha B, et al. Ly6c
+ "inflammatory monocytes" are microglial precursors recruited in a
pathogenic manner in West Nile virus encephalitis. J Exp Med. 2008;205:
2319–37. doi:10.1084/jem.20080421.
34. Lim JK, Obara CJ, Rivollier A, Pletnev AG, Kelsall BL, Murphy PM.
Chemokine receptor Ccr2 is critical for monocyte accumulation and
survival in West Nile virus encephalitis. J Immunol. 2011;186:471–8. doi:
10.4049/jimmunol.1003003.
35. Ben-Nathan D, Huitinga I, Lustig S, van Rooijen N, Kobiler D. West Nile virus
neuroinvasion and encephalitis induced by macrophage depletion in mice.
Arch Virol. 1996;141:459–69.
36. Iijima N, Mattei LM, Iwasaki A. Recruited inflammatory monocytes stimulate
antiviral Th1 immunity in infected tissue. Proc Natl Acad Sci U S A. 2011;108:
284–9. doi:10.1073/pnas.1005201108.
37. Chen BP, Kuziel WA, Lane TE. Lack of CCR2 results in increased mortality
and impaired leukocyte activation and trafficking following infection of
the central nervous system with a neurotropic coronavirus. J Immunol.
2001;167:4585–92.
38. Larena M, Regner M, Lobigs M. Cytolytic effector pathways and IFN-gamma
help protect against Japanese encephalitis. Eur J Immunol. 2013;43:1789–98.
doi:10.1002/eji.201243152.
39. Pujhari SK, Prabhakar S, Ratho R, Mishra B, Modi M, Sharma S, et al. Th1
immune response takeover among patients with severe Japanese
encephalitis infection. J Neuroimmunol. 2013;263:133–8. doi:10.1016/j.
jneuroim.2013.08.003.
40. Larena M, Regner M, Lee E, Lobigs M. Pivotal role of antibody and
subsidiary contribution of CD8+ T cells to recovery from infection in a
murine model of Japanese encephalitis. J Virol. 2011;85:5446–55. doi:10.
1128/JVI.02611-10.
41. Kumar P, Sulochana P, Nirmala G, Chandrashekar R, Haridattatreya M,
Satchidanandam V. Impaired T helper 1 function of nonstructural protein 3-
specific T cells in Japanese patients with encephalitis with neurological
sequelae. J Infect Dis. 2004;189:880–91. doi:10.1086/381768.
42. Eleftheriadis T, Sparopoulou T, Antoniadi G, Liakopoulos V, Stefanidis I,
Galaktidou G. Suppression of humoral immune response to hepatitis B surface
antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration.
Daru. 2011;19:236–9.
43. Harrington L, Srikanth CV, Antony R, Rhee SJ, Mellor AL, Shi HN, et al.
Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced
antibody responses and protects against citrobacter rodentium-induced colitis.
Infect Immun. 2008;76:3045–53. doi:10.1128/IAI.00193-08.
44. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, et al.
Tregs control the development of symptomatic West Nile virus infection in
humans and mice. J Clin Invest. 2009;119:3266–77. doi:10.1172/JCI39387.
45. McWilliams IL, Rajbhandari R, Nozell S, Benveniste E, Harrington LE. STAT4
controls GM-CSF production by both Th1 and Th17 cells during EAE. J
Neuroinflammation. 2015;12:128. doi:10.1186/s12974-015-0351-3.
46. Gonzalez H, Pacheco R. T-cell-mediated regulation of neuroinflammation
involved in neurodegenerative diseases. J Neuroinflammation. 2014;11:201.
doi:10.1186/s12974-014-0201-8.
47. Mailer RK, Joly AL, Liu S, Elias S, Tegner J, Andersson J. IL-1beta promotes
Th17 differentiation by inducing alternative splicing of FOXP3. Sci Rep. 2015;
5:14674. doi:10.1038/srep14674.
48. Falivene J, Ghiglione Y, Laufer N, Eugenia Socias M, Pia Holgado M, Julia Ruiz M,
et al. Th17 and Th17/Treg ratio at early HIV infection associate with protective
HIV-specific CD8(+) T-cell responses and disease progression. Sci Rep. 2015;5:
11511. doi:10.1038/srep11511.
49. Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, et al. The regulation of the
Treg/Th17 balance by mesenchymal stem cells in human systemic lupus
erythematosus. Cell Mol Immunol. 2015. doi: 10.1038/cmi.2015.89
50. Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H, et al. IDO upregulates
regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T
cell responses in experimental autoimmune encephalomyelitis. J Immunol.
2010;185:5953–61. doi:10.4049/jimmunol.1001628.
51. Mahlakoiv T, Hernandez P, Gronke K, Diefenbach A, Staeheli P. Leukocyte-
derived IFN-alpha/beta and epithelial IFN-lambda constitute a
compartmentalized mucosal defense system that restricts enteric virus
infections. PLoS Pathog. 2015;11, e1004782. doi:10.1371/journal.ppat.1004782.
52. Wang BX, Fish EN. The yin and yang of viruses and interferons. Trends
Immunol. 2012;33:190–7. doi:10.1016/j.it.2012.01.004.
53. Hoogland IC, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D.
Systemic inflammation and microglial activation: systematic review of animal
experiments. J Neuroinflammation. 2015;12:114. doi:10.1186/s12974-015-0332-6.
54. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, et al. Neurons
produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A.
2006;103:7835–40.
55. Minter MR, Main BS, Brody KM, Zhang M, Taylor JM, Crack PJ. Soluble
amyloid triggers a myeloid differentiation factor 88 and interferon
regulatory factor 7 dependent neuronal type-1 interferon response in vitro.
J Neuroinflammation. 2015;12:71. doi:10.1186/s12974-015-0263-2.
56. Denney L, Kok WL, Cole SL, Sanderson S, McMichael AJ, Ho LP. Activation of
invariant NKT cells in early phase of experimental autoimmune
encephalomyelitis results in differentiation of Ly6Chi inflammatory
monocyte to M2 macrophages and improved outcome. J Immunol. 2012;
189:551–7. doi:10.4049/jimmunol.1103608.
57. Hesske L, Vincenzetti C, Heikenwalder M, Prinz M, Reith W, Fontana A, et al.
Induction of inhibitory central nervous system-derived and stimulatory
blood-derived dendritic cells suggests a dual role for granulocyte-
macrophage colony-stimulating factor in central nervous system
inflammation. Brain. 2010;133:1637–54. doi:10.1093/brain/awq081.
58. Ifergan I, Kebir H, Bernard M, Wosik K, Dodelet-Devillers A, Cayrol R, et al. The
blood-brain barrier induces differentiation of migrating monocytes into Th17-
polarizing dendritic cells. Brain. 2008;131:785–99. doi:10.1093/brain/awm295.
59. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. B cells and antibody
play critical roles in the immediate defense of disseminated infection by
West Nile encephalitis virus. J Virol. 2003;77:2578–86.
60. Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, Fikrig E, et al. Gamma
interferon plays a crucial early antiviral role in protection against West Nile
virus infection. J Virol. 2006;80:5338–48. doi:10.1128/JVI.00274-06.
61. Fagundes CT, Costa VV, Cisalpino D, Amaral FA, Souza PR, Ryffel B, et al. IFN-
gamma production depends on IL-12 and IL-18 combined action and
mediates host resistance to dengue virus infection in a nitric oxide-dependent
manner. PLoS Negl Trop Dis. 2011;5, e1449. doi:10.1371/journal.pntd.0001449.
62. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. Interferon-
dependent immunity is essential for resistance to primary dengue virus
infection in mice, whereas T- and B-cell-dependent immunity are less
critical. J Virol. 2004;78:2701–10.
63. Wang Y, Lobigs M, Lee E, Koskinen A, Mullbacher A. CD8(+) T cell-mediated
immune responses in West Nile virus (Sarafend strain) encephalitis are
independent of gamma interferon. J Gen Virol. 2006;87:3599–609. doi:10.
1099/vir.0.81306-0.
64. Liu T, Chambers TJ. Yellow fever virus encephalitis: properties of the brain-
associated T-cell response during virus clearance in normal and gamma
interferon-deficient mice and requirement for CD4+ lymphocytes. J Virol.
2001;75:2107–18. doi:10.1128/JVI.75.5.2107-2118.2001.
65. Meier KC, Gardner CL, Khoretonenko MV, Klimstra WB, Ryman KD. A mouse
model for studying viscerotropic disease caused by yellow fever virus
infection. PLoS Pathog. 2009;5, e1000614. doi:10.1371/journal.ppat.1000614.
66. Lobigs M, Mullbacher A, Wang Y, Pavy M, Lee E. Role of type I and type II
interferon responses in recovery from infection with an encephalitic
flavivirus. J Gen Virol. 2003;84:567–72. doi:10.1099/vir.0.18654-0.
67. Chen HW, Pan CH, Huan HW, Liau MY, Chiang JR, Tao MH. Suppression of
immune response and protective immunity to a Japanese encephalitis virus
DNA vaccine by coadministration of an IL-12-expressing plasmid. J
Immunol. 2001;166:7419–26. doi:10.1073/pnas.0602460103.
68. Lin FC, Young HA. Interferons: success in anti-viral immunotherapy. Cytokine
Growth Factor Rev. 2014;25:369–76. doi:10.1016/j.cytogfr.2014.07.015.
69. Eljaafari A, Li YP, Miossec P. IFN-gamma, as secreted during an
alloresponse, induces differentiation of monocytes into tolerogenic
dendritic cells, resulting in FoxP3+ regulatory T cell promotion. J
Immunol. 2009;183:2932–45. doi:10.4049/jimmunol.0804352.
Kim et al. Journal of Neuroinflammation  (2016) 13:79 Page 22 of 23
70. Kerkar SP, Chinnasamy D, Hadi N, Melenhorst J, Muranski P, Spyridonidis
A. Timing and intensity of exposure to interferon-gamma critically
determines the function of monocyte-derived dendritic cells.
Immunology. 2014;143:96–108. doi:10.1111/imm.12292.
71. Lobigs M, Mullbacher A, Regner M. MHC class I up-regulation by flaviviruses:
immune interaction with unknown advantage to host or pathogen.
Immunol Cell Biol. 2003;81:217–23. doi:10.1046/j.1440-1711.2003.01161.x.
72. Suh HS, Zhao ML, Rivieccio M, Choi S, Connolly E, Zhao Y, et al.
Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand
poly(I:C): mechanism of induction and role in antiviral response. J Virol.
2007;81:9838–50. doi:10.1128/JVI.00792-07.
73. Aleyas AG, Han YW, Patil AM, Kim SB, Kim K, Eo SK. Impaired cross-presentation
of CD8alpha + CD11c + dendritic cells by Japanese encephalitis virus in a TLR2/
MyD88 signal pathway-dependent manner. Eur J Immunol. 2012;42:2655–66.
doi:10.1002/eji.201142052.
74. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BRG, et al. PKR
and RNase L contribute to protection against lethal West Nile virus infection
by controlling early viral spread in the periphery and replication in neurons.
J Virol. 2006;80:7009–19.
75. Rohrig UF, Majjigapu SR, Vogel P, Zoete V, Michielin O. Challenges in the
discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. J Med Chem.
2015. doi: 10.1021/acs.jmedchem.5b00326
76. Jiang T, Sun Y, Yin Z, Feng S, Sun L, Li Z. Research progress of
indoleamine 2,3-dioxygenase inhibitors. Future Med Chem. 2015;7:
185–201. doi:10.4155/fmc.14.151.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kim et al. Journal of Neuroinflammation  (2016) 13:79 Page 23 of 23
